Dermatology Times, February 2024 (Vol. 45. No. 02)

Learn more about the in-depth topics covered in the February 2024 print issue of Dermatology Times.

This month's Legal Eagle column highlights the tension between cost control measures and concerns about patient care in the context of health care spending and the increasing prevalence of actinic keratoses

Learn more about dupilumab-induced conjunctivitis rates and misconceptions, the thriving long-term efficacy of dupilumab over 3 years, and unraveling the itch-flare dynamic in abrocitinib treatment.

From the February cover: Joseph Zabinski, PhD, MEM, and Stefan Weiss, MD, MBA, FAAD, share their expertise into AI’s capabilities in dermatology and specifically, rare diseases such as generalized pustular psoriasis.

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.

In this month’s Cosmetic Conundrums column, explore skin barrier assessments, skin moisturization tests, and how to measure skin firmness.

The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels to various cities throughout the country in an RV, wherein volunteer dermatologists provide on-the-street, free-of-cost skin screenings.

A discussion among roundtable participants revolved around the importance of effective communication, the impact of prolonged use of topical steroids, and the need for trust building in recommending novel treatment options.

Star Trek may call space “the final frontier,” but it’s really the next exciting frontier for humans. For now, we can learn about the various new innovations and therapies for skin disease at the AAD annual meeting—and continue to strive to improve our patients’ lives here on Earth.

This year is already off to a busy start, and Dermatology Times is prepared to provide our readers with the most up-to-date clinical content from innovative studies and FDA approvals to exclusive interviews and expert insights.

Paul Friedman, MD, discusses the benefits of UltraClear Laser-Coring, patient downtime, how to decide what devices to have in your clinic, and more.

Tapinarof is showing promise in the landscape of dermatological treatment. Adelaide Hebert, MD, FAAD, recently served as an investigator for 2 studies presented at the European Academy of Dermatology and Venereology (EADV) Congress and discussed key points with Raj Chovatiya, MD, PhD.